These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26404183)

  • 1. Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
    Shu CA; Zhou Q; Jotwani AR; Iasonos A; Leitao MM; Konner JA; Aghajanian CA
    Gynecol Oncol; 2015 Nov; 139(2):236-41. PubMed ID: 26404183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
    Hoskins PJ; Le N; Gilks B; Tinker A; Santos J; Wong F; Swenerton KD
    J Clin Oncol; 2012 May; 30(14):1656-62. PubMed ID: 22493415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
    Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma.
    Hogen L; Thomas G; Bernardini M; Bassiouny D; Brar H; Gien LT; Rosen B; Le L; Vicus D
    Gynecol Oncol; 2016 Nov; 143(2):258-263. PubMed ID: 27623251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
    Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
    Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma.
    Kawabata A; Yanaihara N; Nagata C; Saito M; Noguchi D; Takenaka M; Iida Y; Takano H; Yamada K; Iwamoto M; Kiyokawa T; Okamoto A
    Gynecol Oncol; 2017 Sep; 146(3):609-614. PubMed ID: 28673661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chemotherapy, Laparoscopy, and Cytology on Stage IC Ovarian Clear Cell Carcinoma: A Long-Term, Single-Center Study.
    Chang HT; Chiu ML; Wang TY; Chen TC; Chang CL; Su TH; Wang KG; Wang KL; Yang YC; Chen JR
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Oliver KE; Brady WE; Birrer M; Gershenson DM; Fleming G; Copeland LJ; Tewari K; Argenta PA; Mannel RS; Secord AA; Stephan JM; Mutch DG; Stehman FB; Muggia FM; Rose PG; Armstrong DK; Bookman MA; Burger RA; Farley JH
    Gynecol Oncol; 2017 Nov; 147(2):243-249. PubMed ID: 28807367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
    Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
    Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
    Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
    Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
    Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
    Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic determinants in patients with uterine and ovarian clear carcinoma.
    Rauh-Hain JA; Winograd D; Growdon WB; Schorge JO; Goodman AK; Boruta DM; Berkowitz RS; Horowitz NS; Del Carmen MG
    Gynecol Oncol; 2012 May; 125(2):376-80. PubMed ID: 22366593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
    Diaz ES; Walts AE; Karlan BY; Walsh CS
    Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Vardar MA; Khatib G; Gumurdulu D
    Arch Gynecol Obstet; 2015 Oct; 292(4):923-9. PubMed ID: 25855053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
    Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
    Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.